Loading…

Factors that affect cost and clinical outcome of endovascular aortic repair for abdominal aortic aneurysm

Abstract Objective This study evaluated the effect of indication for use (IFU), additional graft components, and percutaneous closure of endovascular aortic repair (PEVAR) on clinical outcomes and cost of endovascular aortic repair (EVAR). Methods Clinical and financial data were obtained for all el...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery 2017-04, Vol.65 (4), p.997-1005
Main Authors: O'Brien-Irr, Monica S., MS, RN, Harris, Linda M., MD, Dosluoglu, Hasan H., MD, Cherr, Gregory S., MD, Rivero, Mariel, MD, Noor, Sonya, MD, Curl, G. Richard, MD, Dryjski, Maciej L., MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-82a45fe873496ef17fe14d0d6429fcc8bb5302e3d10e6397beaead20d9cb4e873
cites cdi_FETCH-LOGICAL-c451t-82a45fe873496ef17fe14d0d6429fcc8bb5302e3d10e6397beaead20d9cb4e873
container_end_page 1005
container_issue 4
container_start_page 997
container_title Journal of vascular surgery
container_volume 65
creator O'Brien-Irr, Monica S., MS, RN
Harris, Linda M., MD
Dosluoglu, Hasan H., MD
Cherr, Gregory S., MD
Rivero, Mariel, MD
Noor, Sonya, MD
Curl, G. Richard, MD
Dryjski, Maciej L., MD, PhD
description Abstract Objective This study evaluated the effect of indication for use (IFU), additional graft components, and percutaneous closure of endovascular aortic repair (PEVAR) on clinical outcomes and cost of endovascular aortic repair (EVAR). Methods Clinical and financial data were obtained for all elective EVARs completed at a university-affiliated medical center between January 2012 and June 2013. Data were analyzed by χ2 , Student t -test for independent samples, and Kaplan-Meier survival. Results There were 67 elective EVARs. Additional cuffs/extensions were used in 37%, increasing the baseline graft cost by 36% ( P  < .001), total costs by 20% ( P  < .001), and negatively affecting the contribution margin. Aortic neck IFU ( P  = .02), failure of the index graft to seal the neck ( P  = .02), and need for an additional cuff ( P  = .008) were related to the need for reintervention for type Ia endoleak for graft B (Excluder; W. L. Gore and Associates, Flagstaff, Ariz), whereas limb IFU was related to the need for additional limb extension for graft A (Powerlink; Endologix, Irvine, Calif; P  < .001). Limb extension ( P  = .06) and failure of the index graft to provide an adequate seal ( P  < .001) were associated with reintervention for type Ib endoleak. Reintervention-free rates at 24 months were 96% for graft A and 94% for graft B ( P  =.54), but different patterns in reintervention emerged: graft A required reoperation early (
doi_str_mv 10.1016/j.jvs.2016.08.090
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1854613912</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0741521416311272</els_id><sourcerecordid>1854613912</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-82a45fe873496ef17fe14d0d6429fcc8bb5302e3d10e6397beaead20d9cb4e873</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVpaLZpf0AvRcde7Ghk2ZYpFEpI0kAgh7ZnIUsjKte2tpK9sP8-MrvpoYee9JDeGzTfI-QDsBIYNNdDORxSybMsmSxZx16RHbCuLRrJutdkx1oBRc1BXJK3KQ2MAdSyfUMuuWSVyHJH_J02S4iJLr_0QrVzaBZqQsp6ttSMfvZGjzSsiwkT0uAozjYcdDLrqCPVIS7e0Ih77SN1Id_0Nkx-zpnzm55xjcc0vSMXTo8J35_PK_Lz7vbHzbfi8en-4ebrY2FEDUshuRa1Q9lWomvQQesQhGW2Ebxzxsi-ryvGsbLAsKm6tkeN2nJmO9OLLXZFPp3m7mP4s2Ja1OSTwXHMHwlrUiBr0UDVAc9WOFlNDClFdGof_aTjUQFTG2E1qExYbYQVkyoTzpmP5_FrP6H9m3hBmg2fTwbMSx48RpWMx9mg9THDVTb4_47_8k_6pYPfeMQ0hDVmtnkLlbhi6vtW8dYwNBUAb3n1DE80orM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1854613912</pqid></control><display><type>article</type><title>Factors that affect cost and clinical outcome of endovascular aortic repair for abdominal aortic aneurysm</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>O'Brien-Irr, Monica S., MS, RN ; Harris, Linda M., MD ; Dosluoglu, Hasan H., MD ; Cherr, Gregory S., MD ; Rivero, Mariel, MD ; Noor, Sonya, MD ; Curl, G. Richard, MD ; Dryjski, Maciej L., MD, PhD</creator><creatorcontrib>O'Brien-Irr, Monica S., MS, RN ; Harris, Linda M., MD ; Dosluoglu, Hasan H., MD ; Cherr, Gregory S., MD ; Rivero, Mariel, MD ; Noor, Sonya, MD ; Curl, G. Richard, MD ; Dryjski, Maciej L., MD, PhD</creatorcontrib><description><![CDATA[Abstract Objective This study evaluated the effect of indication for use (IFU), additional graft components, and percutaneous closure of endovascular aortic repair (PEVAR) on clinical outcomes and cost of endovascular aortic repair (EVAR). Methods Clinical and financial data were obtained for all elective EVARs completed at a university-affiliated medical center between January 2012 and June 2013. Data were analyzed by χ2 , Student t -test for independent samples, and Kaplan-Meier survival. Results There were 67 elective EVARs. Additional cuffs/extensions were used in 37%, increasing the baseline graft cost by 36% ( P  < .001), total costs by 20% ( P  < .001), and negatively affecting the contribution margin. Aortic neck IFU ( P  = .02), failure of the index graft to seal the neck ( P  = .02), and need for an additional cuff ( P  = .008) were related to the need for reintervention for type Ia endoleak for graft B (Excluder; W. L. Gore and Associates, Flagstaff, Ariz), whereas limb IFU was related to the need for additional limb extension for graft A (Powerlink; Endologix, Irvine, Calif; P  < .001). Limb extension ( P  = .06) and failure of the index graft to provide an adequate seal ( P  < .001) were associated with reintervention for type Ib endoleak. Reintervention-free rates at 24 months were 96% for graft A and 94% for graft B ( P  =.54), but different patterns in reintervention emerged: graft A required reoperation early (<2 months) then stabilized; graft B did not require reintervention until 24 months, but rates increased substantially by 25 months. PEVAR was attempted in 61 (91%): 49 (73%) bilaterally, 7 (10%) unilaterally, and 5 (8%) failed. The mean number of closure devices was four (range, 1-9): $1000 (3.5% of total cost). Bilateral PEVAR was associated with shorter operating time than unilateral PEVAR/failed PEVAR ( P  < .001) and lower operating room use costs ( P  = .005) and total hospital costs ( P  = .003) than failed PEVAR. The contribution margin was higher for bilateral PEVAR than unilateral PEVAR/failed PEVAR ( P  = .005). Patients with bilateral PEVAR and unilateral PEVAR were more often discharged on postoperative day 1 than those with failed PEVAR ( P  = .002). Hospital length of stay ( P  = .49), operating room duration ( P  = .31), and total costs ( P  = .72) were similar for unsuccessful PEVAR and EVAR completed with cutdown. Conclusions Higher rates of reintervention occurred when EVAR was performed outside of IFU guidelines or when additional components were needed. Additions raised graft costs significantly above baseline. Notable differences in graft performance in complex anatomy and varied patterns of reoperation could be useful in the graft selection process to improve outcome and contain costs. Bilateral PEVAR was associated with lower costs and postoperative day 1 discharge. Attempting PEVAR may be reasonable unless there is serious concern for failure.]]></description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2016.08.090</identifier><identifier>PMID: 28034587</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Academic Medical Centers - economics ; Aged ; Aged, 80 and over ; Aortic Aneurysm, Abdominal - diagnostic imaging ; Aortic Aneurysm, Abdominal - economics ; Aortic Aneurysm, Abdominal - mortality ; Aortic Aneurysm, Abdominal - surgery ; Blood Vessel Prosthesis - economics ; Blood Vessel Prosthesis Implantation - adverse effects ; Blood Vessel Prosthesis Implantation - economics ; Blood Vessel Prosthesis Implantation - instrumentation ; Blood Vessel Prosthesis Implantation - mortality ; Chi-Square Distribution ; Cost Savings ; Cost-Benefit Analysis ; Disease-Free Survival ; Endovascular Procedures - adverse effects ; Endovascular Procedures - economics ; Endovascular Procedures - instrumentation ; Endovascular Procedures - mortality ; Female ; Hospital Costs ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; New York ; Postoperative Complications - economics ; Postoperative Complications - etiology ; Postoperative Complications - therapy ; Prosthesis Design ; Retreatment - economics ; Retrospective Studies ; Risk Factors ; Surgery ; Time Factors ; Treatment Outcome</subject><ispartof>Journal of vascular surgery, 2017-04, Vol.65 (4), p.997-1005</ispartof><rights>Society for Vascular Surgery</rights><rights>2016 Society for Vascular Surgery</rights><rights>Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-82a45fe873496ef17fe14d0d6429fcc8bb5302e3d10e6397beaead20d9cb4e873</citedby><cites>FETCH-LOGICAL-c451t-82a45fe873496ef17fe14d0d6429fcc8bb5302e3d10e6397beaead20d9cb4e873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28034587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Brien-Irr, Monica S., MS, RN</creatorcontrib><creatorcontrib>Harris, Linda M., MD</creatorcontrib><creatorcontrib>Dosluoglu, Hasan H., MD</creatorcontrib><creatorcontrib>Cherr, Gregory S., MD</creatorcontrib><creatorcontrib>Rivero, Mariel, MD</creatorcontrib><creatorcontrib>Noor, Sonya, MD</creatorcontrib><creatorcontrib>Curl, G. Richard, MD</creatorcontrib><creatorcontrib>Dryjski, Maciej L., MD, PhD</creatorcontrib><title>Factors that affect cost and clinical outcome of endovascular aortic repair for abdominal aortic aneurysm</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description><![CDATA[Abstract Objective This study evaluated the effect of indication for use (IFU), additional graft components, and percutaneous closure of endovascular aortic repair (PEVAR) on clinical outcomes and cost of endovascular aortic repair (EVAR). Methods Clinical and financial data were obtained for all elective EVARs completed at a university-affiliated medical center between January 2012 and June 2013. Data were analyzed by χ2 , Student t -test for independent samples, and Kaplan-Meier survival. Results There were 67 elective EVARs. Additional cuffs/extensions were used in 37%, increasing the baseline graft cost by 36% ( P  < .001), total costs by 20% ( P  < .001), and negatively affecting the contribution margin. Aortic neck IFU ( P  = .02), failure of the index graft to seal the neck ( P  = .02), and need for an additional cuff ( P  = .008) were related to the need for reintervention for type Ia endoleak for graft B (Excluder; W. L. Gore and Associates, Flagstaff, Ariz), whereas limb IFU was related to the need for additional limb extension for graft A (Powerlink; Endologix, Irvine, Calif; P  < .001). Limb extension ( P  = .06) and failure of the index graft to provide an adequate seal ( P  < .001) were associated with reintervention for type Ib endoleak. Reintervention-free rates at 24 months were 96% for graft A and 94% for graft B ( P  =.54), but different patterns in reintervention emerged: graft A required reoperation early (<2 months) then stabilized; graft B did not require reintervention until 24 months, but rates increased substantially by 25 months. PEVAR was attempted in 61 (91%): 49 (73%) bilaterally, 7 (10%) unilaterally, and 5 (8%) failed. The mean number of closure devices was four (range, 1-9): $1000 (3.5% of total cost). Bilateral PEVAR was associated with shorter operating time than unilateral PEVAR/failed PEVAR ( P  < .001) and lower operating room use costs ( P  = .005) and total hospital costs ( P  = .003) than failed PEVAR. The contribution margin was higher for bilateral PEVAR than unilateral PEVAR/failed PEVAR ( P  = .005). Patients with bilateral PEVAR and unilateral PEVAR were more often discharged on postoperative day 1 than those with failed PEVAR ( P  = .002). Hospital length of stay ( P  = .49), operating room duration ( P  = .31), and total costs ( P  = .72) were similar for unsuccessful PEVAR and EVAR completed with cutdown. Conclusions Higher rates of reintervention occurred when EVAR was performed outside of IFU guidelines or when additional components were needed. Additions raised graft costs significantly above baseline. Notable differences in graft performance in complex anatomy and varied patterns of reoperation could be useful in the graft selection process to improve outcome and contain costs. Bilateral PEVAR was associated with lower costs and postoperative day 1 discharge. Attempting PEVAR may be reasonable unless there is serious concern for failure.]]></description><subject>Academic Medical Centers - economics</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aortic Aneurysm, Abdominal - diagnostic imaging</subject><subject>Aortic Aneurysm, Abdominal - economics</subject><subject>Aortic Aneurysm, Abdominal - mortality</subject><subject>Aortic Aneurysm, Abdominal - surgery</subject><subject>Blood Vessel Prosthesis - economics</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - economics</subject><subject>Blood Vessel Prosthesis Implantation - instrumentation</subject><subject>Blood Vessel Prosthesis Implantation - mortality</subject><subject>Chi-Square Distribution</subject><subject>Cost Savings</subject><subject>Cost-Benefit Analysis</subject><subject>Disease-Free Survival</subject><subject>Endovascular Procedures - adverse effects</subject><subject>Endovascular Procedures - economics</subject><subject>Endovascular Procedures - instrumentation</subject><subject>Endovascular Procedures - mortality</subject><subject>Female</subject><subject>Hospital Costs</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>New York</subject><subject>Postoperative Complications - economics</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - therapy</subject><subject>Prosthesis Design</subject><subject>Retreatment - economics</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kUFr3DAQhUVpaLZpf0AvRcde7Ghk2ZYpFEpI0kAgh7ZnIUsjKte2tpK9sP8-MrvpoYee9JDeGzTfI-QDsBIYNNdDORxSybMsmSxZx16RHbCuLRrJutdkx1oBRc1BXJK3KQ2MAdSyfUMuuWSVyHJH_J02S4iJLr_0QrVzaBZqQsp6ttSMfvZGjzSsiwkT0uAozjYcdDLrqCPVIS7e0Ih77SN1Id_0Nkx-zpnzm55xjcc0vSMXTo8J35_PK_Lz7vbHzbfi8en-4ebrY2FEDUshuRa1Q9lWomvQQesQhGW2Ebxzxsi-ryvGsbLAsKm6tkeN2nJmO9OLLXZFPp3m7mP4s2Ja1OSTwXHMHwlrUiBr0UDVAc9WOFlNDClFdGof_aTjUQFTG2E1qExYbYQVkyoTzpmP5_FrP6H9m3hBmg2fTwbMSx48RpWMx9mg9THDVTb4_47_8k_6pYPfeMQ0hDVmtnkLlbhi6vtW8dYwNBUAb3n1DE80orM</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>O'Brien-Irr, Monica S., MS, RN</creator><creator>Harris, Linda M., MD</creator><creator>Dosluoglu, Hasan H., MD</creator><creator>Cherr, Gregory S., MD</creator><creator>Rivero, Mariel, MD</creator><creator>Noor, Sonya, MD</creator><creator>Curl, G. Richard, MD</creator><creator>Dryjski, Maciej L., MD, PhD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Factors that affect cost and clinical outcome of endovascular aortic repair for abdominal aortic aneurysm</title><author>O'Brien-Irr, Monica S., MS, RN ; Harris, Linda M., MD ; Dosluoglu, Hasan H., MD ; Cherr, Gregory S., MD ; Rivero, Mariel, MD ; Noor, Sonya, MD ; Curl, G. Richard, MD ; Dryjski, Maciej L., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-82a45fe873496ef17fe14d0d6429fcc8bb5302e3d10e6397beaead20d9cb4e873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Academic Medical Centers - economics</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aortic Aneurysm, Abdominal - diagnostic imaging</topic><topic>Aortic Aneurysm, Abdominal - economics</topic><topic>Aortic Aneurysm, Abdominal - mortality</topic><topic>Aortic Aneurysm, Abdominal - surgery</topic><topic>Blood Vessel Prosthesis - economics</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - economics</topic><topic>Blood Vessel Prosthesis Implantation - instrumentation</topic><topic>Blood Vessel Prosthesis Implantation - mortality</topic><topic>Chi-Square Distribution</topic><topic>Cost Savings</topic><topic>Cost-Benefit Analysis</topic><topic>Disease-Free Survival</topic><topic>Endovascular Procedures - adverse effects</topic><topic>Endovascular Procedures - economics</topic><topic>Endovascular Procedures - instrumentation</topic><topic>Endovascular Procedures - mortality</topic><topic>Female</topic><topic>Hospital Costs</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>New York</topic><topic>Postoperative Complications - economics</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - therapy</topic><topic>Prosthesis Design</topic><topic>Retreatment - economics</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Brien-Irr, Monica S., MS, RN</creatorcontrib><creatorcontrib>Harris, Linda M., MD</creatorcontrib><creatorcontrib>Dosluoglu, Hasan H., MD</creatorcontrib><creatorcontrib>Cherr, Gregory S., MD</creatorcontrib><creatorcontrib>Rivero, Mariel, MD</creatorcontrib><creatorcontrib>Noor, Sonya, MD</creatorcontrib><creatorcontrib>Curl, G. Richard, MD</creatorcontrib><creatorcontrib>Dryjski, Maciej L., MD, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Brien-Irr, Monica S., MS, RN</au><au>Harris, Linda M., MD</au><au>Dosluoglu, Hasan H., MD</au><au>Cherr, Gregory S., MD</au><au>Rivero, Mariel, MD</au><au>Noor, Sonya, MD</au><au>Curl, G. Richard, MD</au><au>Dryjski, Maciej L., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors that affect cost and clinical outcome of endovascular aortic repair for abdominal aortic aneurysm</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>65</volume><issue>4</issue><spage>997</spage><epage>1005</epage><pages>997-1005</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract><![CDATA[Abstract Objective This study evaluated the effect of indication for use (IFU), additional graft components, and percutaneous closure of endovascular aortic repair (PEVAR) on clinical outcomes and cost of endovascular aortic repair (EVAR). Methods Clinical and financial data were obtained for all elective EVARs completed at a university-affiliated medical center between January 2012 and June 2013. Data were analyzed by χ2 , Student t -test for independent samples, and Kaplan-Meier survival. Results There were 67 elective EVARs. Additional cuffs/extensions were used in 37%, increasing the baseline graft cost by 36% ( P  < .001), total costs by 20% ( P  < .001), and negatively affecting the contribution margin. Aortic neck IFU ( P  = .02), failure of the index graft to seal the neck ( P  = .02), and need for an additional cuff ( P  = .008) were related to the need for reintervention for type Ia endoleak for graft B (Excluder; W. L. Gore and Associates, Flagstaff, Ariz), whereas limb IFU was related to the need for additional limb extension for graft A (Powerlink; Endologix, Irvine, Calif; P  < .001). Limb extension ( P  = .06) and failure of the index graft to provide an adequate seal ( P  < .001) were associated with reintervention for type Ib endoleak. Reintervention-free rates at 24 months were 96% for graft A and 94% for graft B ( P  =.54), but different patterns in reintervention emerged: graft A required reoperation early (<2 months) then stabilized; graft B did not require reintervention until 24 months, but rates increased substantially by 25 months. PEVAR was attempted in 61 (91%): 49 (73%) bilaterally, 7 (10%) unilaterally, and 5 (8%) failed. The mean number of closure devices was four (range, 1-9): $1000 (3.5% of total cost). Bilateral PEVAR was associated with shorter operating time than unilateral PEVAR/failed PEVAR ( P  < .001) and lower operating room use costs ( P  = .005) and total hospital costs ( P  = .003) than failed PEVAR. The contribution margin was higher for bilateral PEVAR than unilateral PEVAR/failed PEVAR ( P  = .005). Patients with bilateral PEVAR and unilateral PEVAR were more often discharged on postoperative day 1 than those with failed PEVAR ( P  = .002). Hospital length of stay ( P  = .49), operating room duration ( P  = .31), and total costs ( P  = .72) were similar for unsuccessful PEVAR and EVAR completed with cutdown. Conclusions Higher rates of reintervention occurred when EVAR was performed outside of IFU guidelines or when additional components were needed. Additions raised graft costs significantly above baseline. Notable differences in graft performance in complex anatomy and varied patterns of reoperation could be useful in the graft selection process to improve outcome and contain costs. Bilateral PEVAR was associated with lower costs and postoperative day 1 discharge. Attempting PEVAR may be reasonable unless there is serious concern for failure.]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28034587</pmid><doi>10.1016/j.jvs.2016.08.090</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2017-04, Vol.65 (4), p.997-1005
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_1854613912
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Academic Medical Centers - economics
Aged
Aged, 80 and over
Aortic Aneurysm, Abdominal - diagnostic imaging
Aortic Aneurysm, Abdominal - economics
Aortic Aneurysm, Abdominal - mortality
Aortic Aneurysm, Abdominal - surgery
Blood Vessel Prosthesis - economics
Blood Vessel Prosthesis Implantation - adverse effects
Blood Vessel Prosthesis Implantation - economics
Blood Vessel Prosthesis Implantation - instrumentation
Blood Vessel Prosthesis Implantation - mortality
Chi-Square Distribution
Cost Savings
Cost-Benefit Analysis
Disease-Free Survival
Endovascular Procedures - adverse effects
Endovascular Procedures - economics
Endovascular Procedures - instrumentation
Endovascular Procedures - mortality
Female
Hospital Costs
Humans
Kaplan-Meier Estimate
Male
Middle Aged
New York
Postoperative Complications - economics
Postoperative Complications - etiology
Postoperative Complications - therapy
Prosthesis Design
Retreatment - economics
Retrospective Studies
Risk Factors
Surgery
Time Factors
Treatment Outcome
title Factors that affect cost and clinical outcome of endovascular aortic repair for abdominal aortic aneurysm
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T19%3A17%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20that%20affect%20cost%20and%20clinical%20outcome%20of%20endovascular%20aortic%20repair%20for%20abdominal%20aortic%20aneurysm&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=O'Brien-Irr,%20Monica%20S.,%20MS,%20RN&rft.date=2017-04-01&rft.volume=65&rft.issue=4&rft.spage=997&rft.epage=1005&rft.pages=997-1005&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/j.jvs.2016.08.090&rft_dat=%3Cproquest_cross%3E1854613912%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-82a45fe873496ef17fe14d0d6429fcc8bb5302e3d10e6397beaead20d9cb4e873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1854613912&rft_id=info:pmid/28034587&rfr_iscdi=true